Efficient ph dependent drug delivery to target cancer cells by gold nanoparticles capped with carboxymethyl chitosan

International Journal of Molecular Sciences

Volumn 15, Issue 5, 2014, Pages 8216-8234

  Madhusudhan, Alle ^a   Reddy, Gangapuram Bhagavanth ^a   Venkatesham, Maragoni ^a   Veerabhadram, Guttena ^a   Kumar, Anil Dudde ^a   Natarajan, Sumathi ^a   Yang, Ming Yeh ^b   Hu, Anren ^b   Singh, Surya S ^a  

^a OSMANIA UNIVERSITY   (India)

^b TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Carboxymethyl chitosan; Cellular uptake; Cytotoxicity; Doxorubicin; Gold nanoparticles; Ph sensitive drug delivery

Indexed keywords

CHITOSAN; DOXORUBICIN; GOLD NANOPARTICLE; ANTINEOPLASTIC ANTIBIOTIC; CARBOXYMETHYL-CHITOSAN; DELAYED RELEASE FORMULATION; GOLD; NANOPARTICLE;

ARTICLE; CANCER CELL; CELL VIABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG TUMOR LEVEL; DRUG UPTAKE; ELECTRON DIFFRACTION; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; LIGHT SCATTERING; MOLECULARLY TARGETED THERAPY; PH; SURFACE PLASMON RESONANCE; TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET SPECTROSCOPY; UTERINE CERVIX CANCER; X RAY DIFFRACTION; ANALOGS AND DERIVATIVES; CHEMISTRY; DELAYED RELEASE FORMULATION; METABOLISM; NEOPLASMS; PARTICLE SIZE; TUMOR CELL LINE;

ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE, TUMOR; CHITOSAN; DELAYED-ACTION PREPARATIONS; DOXORUBICIN; DRUG DELIVERY SYSTEMS; GOLD; HUMANS; NANOPARTICLES; NEOPLASMS; PARTICLE SIZE;

EID: 84900034255     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15058216     Document Type: Article

References (62)

1. Gottesman, M.M.; Fojo, T.; Bates, S.E. Multidrug resistance in cancer: Role of ATP-dependent transporters. Nat. Rev. Cancer 2002, 2, 48-58.
2. Maeda, H. SMANCS polymer-conjugated macromolecular drugs: Advantages in cancer chemotherapy. Adv. Drug Deliv. Rev. 2001, 46, 169-185.
3. Oishi, M.; Hayashi, H.; Iijima, M.; Nagasaki, Y. Endosomal release and intracellular delivery of anticancer drugs using pH-sensitive PEGylated nanogels. J. Mater. Chem. 2007, 17, 3720-3725.
4. Szakacs, G.; Paterson, J.K.; Ludwig, J.A.; Genthe, C.B.; Gottesman, M.M. Targeting multidrug resistance in cancer. Nat. Rev. Drug Discov. 2006, 5, 219-234.
5. Vlerken, L.E.V.; Amiji, M.M. Multi-functional polymeric nanoparticles for tumour-targeted drug delivery. Expert Opin. Drug Deliv. 2006, 3, 205-216.
6. Han, G.; Ghosh, P.; Rotello, V.M. Functionalized gold nanoparticles for drug delivery. Nanomedicine 2007, 2, 113-123.
7. Qi, L.; Wu, L.; Zheng, S.; Wang, Y.; Fu, H.; Cui, D.X. Cell-penetrating magnetic nanoparticles for highly efficient delivery and intracellular imaging of siRNA. Biomacromolecules 2012, 13, 2723-2730.
8. Pan, B.F.; Cui, D.X.; Sheng, Y.; Ozkan, C.G.; Gao, F.; He, R.; Li, Q.; Xu, P.; Huang, T. Dendrimer-modified magnetic nanoparticles enhance efficiency of gene delivery system. Cancer Res. 2007, 67, 8156-8163.
9. Huang, P.; Li, Z.M.; Lin, J.; Yang, D.P.; Gao, G.; Xu, C.; Bao, L.; Zhang, C.L.; Wang, K.; Song, H. et al. Photosensitizer-conjugated magnetic nanoparticles for in vivo simultaneous magnetofluorescent imaging and targeting therapy. Biomaterials 2011, 32, 3447-3458.
10. Nowicka, A.M.; Kowalczyk, A.; Jarzebinska, A.; Donten, M.; Krysinski, P.; Stojek, Z. Progress in targeting tumor cells by using drug magnetic nanoparticle conjugated. Biomacromolecules 2013, 14, 828-833.
11. Cheng, M.M.C.; Cuda, G.; Bunimovich, Y.L.; Gaspari, M.; Heath, J.R.; Hill, H.D.; Mirkin, C.A.; Nijdam, A.J.; Terracciano, R.; Thundat, T. et al. Nanotechnologies for biomolecular detection and medical diagnostics. Curr. Opin. Chem. Biol. 2006, 10, 11-19.
12. Ghosh, P.; Han, G.; De, M.; Kim, C.K.; Rotello, V.M. Gold nanoparticles in delivery applications. Adv. Drug Deliv. Rev. 2008, 60, 1307-1315.
13. De, M.; Ghosh, P.S.; Rotello, V.M. Applications of nanoparticles in biology. Adv. Mater. 2008, 20, 4225-4241.
14. Huang, L.; Zhai, M.; Peng, J.; Xu, L.; Li, J.; Wei, G. Synthesis, size control and fluorescence studies of gold nanoparticles in carboxymethylated chitosan aqueous solutions. J. Colloid Interface Sci. 2007, 316, 398-404.
15. Kattumuri, V.; Katti, K.; Bhaskaran, S.; Boote, E.J.; Casteel, S.W.; Fent, G.M.; Robertson, D.J.; Chandrasekhar, M.; Kannan, R.; Katti, K.V. Gum arabic as a phytochemical construct for the stabilization of gold nanoparticles: In vivo pharmacokinetics and X-ray-contrast-imaging studies. Small 2007, 3, 333-341.
16. Shan, J.; Tenhu, H. Recent advances in polymer protected gold nanoparticles: Synthesis, properties and applications. Chem. Commun. 2007, 44, 4580-4598.
17. Paciotti, G.F.; Myer, L.; Weinreich, D.; Goia, D.; Pavel, N.; McLaughlin, R.E.; Tamarkin, L. Colloidal gold: A novel nanoparticle vector for tumor directed drug delivery. Drug Deliv. 2004, 11, 169-183.
18. Hong, R.; Fischer, N.O.; Verma, A.; Goodman, C.M.; Emrick, T.; Rotello, V.M. Control of protein structure and function through surface recognition by tailored nanoparticle scaffolds. J. Am. Chem. Soc. 2004, 126, 739-743.
19. Kim, C.K.; Ghosh, P.; Pagliuca, C.; Zhu, Z.J.; Menichetti, S.; Rotello, V.M. Entrapment of hydrophobic drugs in nanoparticle monolayers with efficient release into cancer cells. J. Am. Chem. Soc. 2009, 131, 1360-1361.
20. Selvakannan, P.; Mandal, S.; Phadtare, S.; Gole, A.; Pasricha, R.; Adyanthaya, S.D.; Sastry, M. Water-dispersible tryptophan-protected gold nanoparticles prepared by the spontaneous reduction of aqueous chloroaurate ions by the amino acid. J. Colloid Interface Sci. 2004, 269, 97-102.
21. Chithrani, B.D.; Chan, W.C.W. Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett. 2007, 7, 1542-1550.
22. Visaria, R.K.; Griffin, R.J.; Williams, B.W.; Ebbini, E.S.; Paciotti, G.F.; Song, C.W.; Bischof, J.C. Enhancement of tumor thermal therapy using gold nanoparticle-assisted tumor necrosis factor-alpha delivery. Mol. Cancer Ther. 2006, 5, 1014-1020.
23. Cheng, Y.; Samia, A.C.; Meyers, J.D.; Panagopoulos, I.; Fei, B.W.; Burda, C. Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer. J. Am. Chem. Soc. 2008, 130, 10643-10647.
24. Ghosh, P.S.; Kim, C.K.; Han, G.; Forbes, N.S.; Rotello, V.M. Efficient gene delivery vectors by tuning the surface charge density of amino acid-functionalized gold nanoparticles. ACS Nano 2008, 2, 2213-2218.
25. Lee, J.S.; Green, J.J.; Love, K.T.; Sunshine, J.; Langer, R.; Anderson, D.J. Gold, poly(β-amino ester) nanoparticles for small interfering RNA delivery. Nano Lett. 2009, 9, 2402-2406.
26. Katz, E.; Willner, I. Integrierte hybrid systeme aus nanopartikeln und biomolekülen: Synthese, eigenschaften and anwendungen. Angew. Chem. 2004, 116, 6166-6135.
27. Hong, R.; Han, G.; Fernandez, J.M.; Kim, B.J.; Forbes, N.S.; Rotello, V.M. Glutathione-mediated delivery and release using monolayer protected nanoparticle carriers. J. Am. Chem. Soc. 2006, 128, 1078-1079.
28. Polizzi, M.A.; Stasko, N.A.; Schoenfisch, M.H. Water-soluble nitric oxide-releasing gold nanoparticles. Langmuir 2007, 23, 4938-4943.
29. Kenneth, F.H.; Annemette, V.T.; Maxwell, S.; Peter, B.J. Dexrazoxane protects against myelosuppression from the DNA cleavage-enhancing drugs etoposide and daunorubicin but not doxorubicin. Clin. Cancer Res. 2005, 11, 3915-3924.
30. Schondorf, T.; Kurbacher, C.M.; Gohring, U.J.; Benz, C.; Becker, M.; Sartorius, J.; Kolhagen, H.; Mallman, P.; Neumann, R. Induction of MDR1-gene expression by antineoplastic agents in ovarian cancer cell lines. Anticancer Res. 2002, 22, 2199-2203.
31. Linn, S.C.; Giaccone, G. MDR1/P-glycoprotein expression in colorectal cancer. Eur. J. Cancer 1995, 31A, 1291-1294.
32. Yu, S.T.; Chen, T.M.; Tseng, S.Y.; Chen, Y.H. Tryptanthrin inhibits MDR1 and reverses doxorubicin resistance in breast cancer cells. Biochem. Biophys. Res. Commun. 2007, 358, 79-84.
33. Shen, D.W.; Fojo, A.; Chin, J.E.; Roninson, I.B.; Richert, N.; Pastan, I. Human multidrug-resistant cell lines: Increased mdr1 expression can precede gene amplification. Science 1986, 232, 643-645.
34. Bareford, L.M.; Swaan, P.W. Endocytic mechanisms for targeted drug delivery. Adv. Drug Deliv. Rev. 2007, 59, 748-758.
35. Zhang, X.; Chibli, H.; Kong, D.; Nadeau, J. Comparative cytotoxicity of gold-doxorubicin and InP-doxorubicin conjugates. Nanotechnology 2012, 23, 275103-275113.
36. Wike-Hooley, J.L.; Haven, J.; Reinhold, H.S. The relevance of tumour pH to the treatment of malignant disease. Radiother. Oncol. 1984, 2, 343-366.
37. Raghunand, N.; Altbach, M.I.; van Sluis, R.; Baggett, B.; Taylor, C.W.; Bhujwalla, Z.M.; Gillies, R.Z. Plasmalemmal pH gradients in drugsensitive and drug-resistant MCF-7 human breast carcinoma xenografts measured by 31P MR spectroscopy. Biochem. Pharmacol. 1999, 57, 309-312.
38. Ojugo, A.S.; McSheehy, P.M.; McIntyre, D.J.; McCoy, C.; Stubbs, M.; Leach, M.O.; Judson, I.R.; Griffiths, J.R. Measurement of the extracellular pH of solid tumours in mice by magnetic resonance spectroscopy: A comparison of exogenous 19F and 31P probes. NMR Biomed. 1997, 12, 495-504.
39. Mark, F.; McCarty, B.A.; Julian, W. Manipulating tumor acidification as a cancer treatment strategy. Alter. Med. Rev. 2010, 15, 264-272.
40. Tannock, I.F.; Rotin, D. Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res. 1989, 49, 4373-4384.
41. Sheetal, D.; Maheswara Reddy, E.; Asmita, P.; Varsha, P.; Anjali, S.; Prasad, B.L.V. Cytotoxicity of sophorolipid-gellan gum-gold nanoparticle conjugates and their doxorubicin loaded derivatives towards human glioma and human glioma stem cell lines. Nanoscale 2011, 3, 575-580.
42. Rouhana, L.L.; Jaber, J.A.; Schlenoff, J.B. Aggregation-resistant water-soluble gold nanoparticles. Langmuir 2007, 23, 12799-12801.
43. Narayanan, K.B.; Sakthivel, N. Coriander leaf mediated biosynthesis of gold nanoparticles. Mater. Lett. 2008, 62, 4588-4591.
44. Bankar, A.; Joshi, B.; Kumar, A.R.; Zinjarde, S. Banana peel extract mediated synthesis of gold nanoparticles. Colloids Surf. B 2010, 80, 45-50.
45. Reddy, A.S.; Chen, C.Y.; Chen, C.C.; Jean, J.S.; Chen, H.R.; Tseng, M.J.; Fan, C.W.; Wang, J.C. Biological synthesis of gold and silver nanoparticles mediated by the bacteria bacillus subtilis. J. Nanosci. Nanotechnol. 2010, 10, 6567-6574.
46. Bhumkar, D.R.; Joshi, H.M.; Sastry, M.; Pokharkar, V.B. Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin. Pharm. Res. 2007, 24, 1415-1426.
47. Sheetal, D.; Maheswara Reddy, E.; Anjali, S.; Varsha, P.; Prasad, B.L.V. Natural gum reduced/stabilized gold nanoparticles for drug delivery formulations. Chem. Eur. J. 2008, 14, 10244-10250.
48. Xu, Q.; Mao, C.; Liu, N.N.; Zhu, J.J.; Sheng, J. Direct electrochemistry of horseradish peroxidase based on biocompatible carboxymethyl chitosan-gold nanoparticle nanocomposite. Biosens. Bioelectron. 2006, 22, 768-773.
49. Brust, M.; Walker, M.; Bethell, D.; Schiffrin, D.J.; Whyman, R. Synthesis of thiol-derivatised gold nanoparticles in a two-phase liquid-liquid system. J. Chem. Soc. Chem. Commun. 1994, 7, 801-802.
50. Hussain, N.; Jaitley, V.; Florence, A.T. Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics. Adv. Drug Deliv. Rev. 2001, 50, 107-142.
51. Kohli, A.K.; Alpar, H.O. Potential use of nanoparticles for transcutaneous vaccine delivery: Effect of particle size and charge. Int. J. Pharm. 2004, 275, 13-17.
52. Yoo, H.S.; Lee, K.H.; Oh, J.E.; Park, T.G. In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugates. J. Control. Release 2000, 68, 419-431.
53. Liu, Z.; Sun, X.; Nakayama-Ratchford, N.; Dai, H. Supramolecular chemistry on water-soluble carbon nanotubes for drug loading and delivery. ACS Nano 2007, 1, 50-56.
54. Liu, Z.; Fan, A.C.; Rakhra, K.; Sherlock, S.; Goodwin, A.; Chen, X.; Yang, Q.; Felsher, D.W.; Dai, H. Supramolecular stacking of doxorubicin on carbon nanotubes for in vivo cancer therapy. Angew. Chem. Int. Ed. 2009, 48, 7668-7672.
55. Aryal, S.; Grailer, J.J.; Pilla, S.; Steeber, D.A.; Gong, S.Q. Doxorubicin conjugated gold nanoparticles as water-soluble and pH-responsive anticancer drug nanocarriers. J. Mater. Chem 2009, 19, 7879-7884.
56. Sunil, P.; Goldie, O.; Ashmi, M.; Ritu, S.; Mukeshch, T.; Madhuri, S. Folic acid mediated synaphic delivery of doxorubicin using biogenic gold nanoparticles anchored to biological linkers. J. Mater. Chem. B 2013, 11, 361-370.
57. Prabaharan, M.; Grailer, J.J.; Pilla, S.; Steeber, D.A.; Gong, S.Q. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery. Biomaterials 2009, 30, 5757-5766.
58. Bhujwalla, Z.M.; Artetmov, D.; Bllestros, P.; Cerdan, S.; Gillies, R.J.; Solaiyappan, M. Combined vascular and extracellular pH imaging of solid tumors. NMR Biomed. 2002, 15, 114-119.
59. Swietach, P.; Hulikova, A.; Patiar, S.; Vaughan-Jones, R.D.; Harris, A.L. Importance of intracellular pH in determining the uptake and efficacy of the weakly basic chemotherapeutic drug, doxorubicin. PLoS One 2012, 7, e35949.
60. Maeda, H. The enhanced permeability and retention (EPR) effect in tumor vasculature: The key role of tumor-selective macromolecular drug targeting. Adv. Enzym. Regul. 2001, 41, 189-207.
61. Hobbs, S.K.; Monsky, W.L.; Yuan, F.; Roberts, W.G.; Griffith, L.; Torchilin, V.P.; Jain, R.K. Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment. Proc. Natl. Acad. Sci. USA 1998, 95, 4607-4612.
62. Patel, N.K.; Sinha, V.K. Characterization and optimization of water-soluble chitosan derivatives. Int. J. Polym. Mater. 2009, 58, 548-560.